ZUBERITAMAB: 25 Adverse Event Reports & Safety Profile
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
25
Total FAERS Reports
1 (4.0%)
Deaths Reported
11
Hospitalizations
25
As Primary/Secondary Suspect
2
Life-Threatening
1
Disabilities
First Report: 20240428 · Latest Report: 20250530
What Are the Most Common ZUBERITAMAB Side Effects?
#1 Most Reported
Lymphocyte count decreased
10 reports (40.0%)
#2 Most Reported
Neutrophil count decreased
9 reports (36.0%)
#3 Most Reported
White blood cell count decreased
7 reports (28.0%)
All ZUBERITAMAB Side Effects by Frequency
| Side Effect | Reports | % of Total | Deaths | Hosp. |
|---|---|---|---|---|
| Lymphocyte count decreased | 10 | 40.0% | 0 | 4 |
| Neutrophil count decreased | 9 | 36.0% | 1 | 5 |
| White blood cell count decreased | 7 | 28.0% | 0 | 4 |
| Myelosuppression | 5 | 20.0% | 0 | 3 |
Who Reports ZUBERITAMAB Side Effects? Age & Gender Data
Gender: 50.0% female, 50.0% male. Average age: 61.7 years. Most reports from: CN. View detailed demographics →
Is ZUBERITAMAB Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2024 | 18 | 1 | 9 |
| 2025 | 6 | 0 | 1 |
What Is ZUBERITAMAB Used For?
| Indication | Reports |
|---|---|
| Diffuse large b-cell lymphoma | 19 |
Official FDA Label for ZUBERITAMAB
Official prescribing information from the FDA-approved drug label.